Exosomal delivery of PGM5‐AS1 and oxaliplatin restored oxaliplatin sensitivity in resistant CRC cells by promoting apoptosis, downregulating progestagen associated endometrial protein (PAEP), and upregulating NME1. Here, PGM5 is linked to colorectal carcinoma.